Search research articles
Contact Us
Filters
Showing results (701-710 of 792) with videos related to
Page
of 80
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Health Research Policy and Systems
|
April 14, 2026
Political economy of adolescent mental health and well-being globally
Olivia Biermann, Yusra Ribhi Shawar, Jeremy Shiffman, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
October 25, 2022
Chilblains outbreak during COVID-19 pandemic: A Type-I interferonopathy?
Anna Mensa-Vilaró, Asunción Vicente, Marta Español-Rego, et al.
Blood
|
December 30, 2017
Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome
Dorota M Rowczenio, Shelly Pathak, Juan I Arostegui, et al.
Infectious Diseases and Therapy
|
July 1, 2025
Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Infectious Diseases and Therapy
|
March 15, 2024
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact
Carolina Garcia-Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, et al.
Vaccine
|
February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2020
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies
Betty B Yao, Linda M Fredrick, Gretja Schnell, et al.
Vaccines
|
February 24, 2024
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S Lowry, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 12, 2019
Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection
D Viasus, P Puerta-Alcalde, C Cardozo, et al.
Page
of 80
Search research articles
Search
Showing results (701-710 of 792) with videos related to
Sort By:
Page
of 80
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector Rodriguez, et al.
Health Research Policy and Systems
|
April 14, 2026
Political economy of adolescent mental health and well-being globally
Olivia Biermann, Yusra Ribhi Shawar, Jeremy Shiffman, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
October 25, 2022
Chilblains outbreak during COVID-19 pandemic: A Type-I interferonopathy?
Anna Mensa-Vilaró, Asunción Vicente, Marta Español-Rego, et al.
Blood
|
December 30, 2017
Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome
Dorota M Rowczenio, Shelly Pathak, Juan I Arostegui, et al.
Infectious Diseases and Therapy
|
July 1, 2025
Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Infectious Diseases and Therapy
|
March 15, 2024
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact
Carolina Garcia-Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, et al.
Vaccine
|
February 25, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old
Oyeniyi Diya, Juleen Gayed, Francine S Lowry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2020
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies
Betty B Yao, Linda M Fredrick, Gretja Schnell, et al.
Vaccines
|
February 24, 2024
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S Lowry, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 12, 2019
Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection
D Viasus, P Puerta-Alcalde, C Cardozo, et al.
Page
of 80